Carbogenics Secures Funding for Sustainable Biochar Innovations
Carbogenics, a pioneering company based in Edinburgh, Scotland, UK, focuses on sustainable biochar technology and has successfully secured nearly GBP500K in funding. This financial boost comes from notable backers, including Green Angel Ventures and Kaplak Ventures. The primary aim of this funding is to accelerate the adoption of their flagship product, CreChar®, which has been designed to meet a variety of environmental needs. Additionally, the company is working on the commercialization of innovative new products, such as FilaChar®, specifically targeted at the waste-water industry, which represents a significant step toward addressing pressing environmental challenges.
As a spinout from the University of Edinburgh, Carbogenics has developed a unique process that transforms hard-to-recycle secondary biomass into CreChar®, a carbon-rich material that offers multiple benefits.
Not only does CreChar® enhance biogas yields, but it also promotes soil health and effectively sequesters carbon for centuries. This technology is particularly important in the current context of climate change and the urgent need for sustainable practices in waste management and agriculture. With this latest infusion of funding, Carbogenics aims to boost key growth initiatives such as new product development, expanding sales efforts, and enhancing its operational footprint in both Europe and North America.
Despite its ambitions on the international stage, Carbogenics remains committed to its roots in the UK, as evidenced by the recent opening of its first post-processing facility in Glenrothes, Scotland, earlier in 2024. This move not only underscores the company's dedication to the local economy but also its commitment to advancing sustainable technologies at home. Under the leadership of CEO Ed Craig, Carbogenics is well-positioned to make a meaningful impact in the field of sustainable biochar technology, contributing to a greener future while driving forward its innovative product offerings in an increasingly eco-conscious market.
They've invested in Carbogenics
Get to know these Healthtech investors
Click here for a full list of 6,481+ startup investors in the UK